Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

National Research (NRC) EBITDA (2016 - 2025)

Historic EBITDA for National Research (NRC) over the last 16 years, with Q3 2025 value amounting to $7.7 million.

  • National Research's EBITDA fell 303.26% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year decrease of 2627.43%. This contributed to the annual value of $35.2 million for FY2024, which is 1211.39% down from last year.
  • National Research's EBITDA amounted to $7.7 million in Q3 2025, which was down 303.26% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, National Research's EBITDA registered a high of $13.1 million during Q3 2021, and its lowest value of $1.6 million during Q2 2025.
  • In the last 5 years, National Research's EBITDA had a median value of $10.0 million in 2023 and averaged $10.0 million.
  • Its EBITDA has fluctuated over the past 5 years, first soared by 3195.69% in 2021, then plummeted by 8208.69% in 2025.
  • Quarter analysis of 5 years shows National Research's EBITDA stood at $12.9 million in 2021, then decreased by 4.91% to $12.2 million in 2022, then decreased by 4.35% to $11.7 million in 2023, then dropped by 18.11% to $9.6 million in 2024, then decreased by 19.29% to $7.7 million in 2025.
  • Its EBITDA was $7.7 million in Q3 2025, compared to $1.6 million in Q2 2025 and $8.6 million in Q1 2025.